Search Results - "Leung, Roland Ching-Yu" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Multimodal Integrative Genomics and Pathology Analyses in Neoadjuvant Nivolumab Treatment for Intermediate and Locally Advanced Hepatocellular Carcinoma

Multimodal Integrative Genomics and Pathology Analyses in Neoadjuvant Nivolumab Treatment for Intermediate and Locally Advanced Hepatocellular Carcinoma

by Cheung, Tan-To, Ho, Daniel Wai-Hung, Lyu, Shirley Xueying, Zhang, Qingyang, Tsui, Yu-Man, Yu, Tiffany Ching-Yun, Sze, Karen Man-Fong, Lee, Joyce Man-Fong, Lau, Vince Wing-hang, Chu, Edward Yin-Lun, Tsang, Simon Hing-Yin, She, Wong-Hoi, Leung, Roland Ching-Yu, Yau, Thomas Chung-Cheung, Ng, Irene Oi-Lin
Published in Liver cancer (Basel ) (01.02.2024)

Get full text

Journal Article

BRCA mutation testing for ovarian cancer in the context of available targeted therapy: Survey and consensus of Hong Kong specialists

BRCA mutation testing for ovarian cancer in the context of available targeted therapy: Survey and consensus of Hong Kong specialists

by Kwong, Ava, Cheng, Ka‐Leung Danny, Hsue, Chan‐Chee Victor, Hui, Sze‐Ki, Leung, Ching‐Yu Roland, Leung, Kwong‐Chuen Angus, Ngan, Kai‐Cheong Roger, Soong, Sung Inda
Published in Asia-Pacific journal of clinical oncology (01.03.2019)

Get full text

Journal Article

Electroacupuncture trigeminal nerve stimulation plus body acupuncture for chemotherapy-induced cognitive impairment in breast cancer patients: An assessor-participant blinded, randomized controlled trial

Electroacupuncture trigeminal nerve stimulation plus body acupuncture for chemotherapy-induced cognitive impairment in breast cancer patients: An assessor-participant blinded, randomized controlled trial

by Zhang, Zhang-Jin, Man, Sui-Cheung, Yam, Lo-Lo, Yiu, Chui Ying, Leung, Roland Ching-Yu, Qin, Zong-Shi, Chan, Kit-Wa Sherry, Lee, Victor Ho Fun, Kwong, Ava, Yeung, Wing-Fai, So, Winnie K.W., Ho, Lai Ming, Dong, Ying-Ying
Published in Brain, behavior, and immunity (01.08.2020)

Get full text

Journal Article

Outcomes of tyrosine kinase inhibitors (TKI) after immunotherapy in unresectable or advanced hepatocellular carcinoma (HCC) patients

Outcomes of tyrosine kinase inhibitors (TKI) after immunotherapy in unresectable or advanced hepatocellular carcinoma (HCC) patients

by Yau, Thomas Cheung, Tang, Vikki, Chan, Jess, Kwok, Gin Wai, Chiu, Joanne, Leung, Roland Ching-Yu, Li, Bryan, Cheung, Tan To
Published in Journal of clinical oncology (01.02.2019)

Get full text

Journal Article

Survival outcomes of young patients under 40 with breast cancer in Asian countries according to subtype: An international multicenter cohort study

Survival outcomes of young patients under 40 with breast cancer in Asian countries according to subtype: An international multicenter cohort study

by Kim, Jinyong, Lee, Kyung-Hun, Park, Yeon Hee, Lin, Ching-Hung, Lu, Yen-Shen, Ueno, Takayuki, Yap, Yoon Sim, Yeo, Winnie, Liu, Qiang, Leung, Roland Ching-Yu, Naito, Yoichi, Li, Huiping, Lee, Han-Byoel, Han, Wonshik, Im, Seock-Ah
Published in Journal of clinical oncology (01.06.2023)

Get full text

Journal Article

A phase 2, open-label, single-arm study evaluating the combination of pembrolizumab (pembro), lenvatinib, and chemotherapy in patients (pts) with metastatic non-small cell lung cancer (NSCLC) harbouring a targetable mutation who experienced disease progression on standard tyrosine kinase inhibitors (TKIs)

A phase 2, open-label, single-arm study evaluating the combination of pembrolizumab (pembro), lenvatinib, and chemotherapy in patients (pts) with metastatic non-small cell lung cancer (NSCLC) harbouring a targetable mutation who experienced disease progression on standard tyrosine kinase inhibitors (TKIs)

by Chan, Hoi Wai, Tse, Chris Chun Long, Li, Yu-Chung, Leung, Roland Ching-Yu, Wong, Jeffrey Sum Lung, Kwok, Gin Wai, Li, Hoi Lam, Tsang, Wing Yan Josephine, Li, Cho Wing, Lo, Jenny WY, Tang, Vikki, Hui, Rina, Yau, Thomas, Ho, James CM, Chiu, Joanne W
Published in Journal of clinical oncology (10.08.2024)

Get full text

Journal Article

Expert consensus recommendations on the daily clinical use of pembrolizumab for early triple-negative breast cancer

Expert consensus recommendations on the daily clinical use of pembrolizumab for early triple-negative breast cancer

by Yeo, Winnie, Chan, Yolanda HY, Leung, Roland Ching-Yu, Chan, Sharon Wing Wai, Chow, Lorraine Chi Yan, Foo, William, Fung, Sara, Kwok, Carol, Lau, Stephanie Hiu Yan, Leung, Alex, Ng, Ting Ying, Tsang, Janice, Wong, Iris, Yau, Chun Chung, Yuen, Ho Yan, Cheung, Polly Suk Yee
Published in Journal of clinical oncology (01.06.2024)

Get full text

Journal Article

First-line inavolisib/placebo + palbociclib + fulvestrant (Inavo/Pbo+Palbo+Fulv) in patients (pts) with PIK3CA -mutated, hormone receptor-positive, HER2-negative locally advanced/metastatic breast cancer who relapsed during/within 12 months (mo) of adjuvant endocrine therapy completion: INAVO120 Phase III randomized trial additional analyses

First-line inavolisib/placebo + palbociclib + fulvestrant (Inavo/Pbo+Palbo+Fulv) in patients (pts) with PIK3CA -mutated, hormone receptor-positive, HER2-negative locally advanced/metastatic breast cancer who relapsed during/within 12 months (mo) of adjuvant endocrine therapy completion: INAVO120 Phase III randomized trial additional analyses

by Juric, Dejan, Kalinsky, Kevin, Turner, Nicholas C., Jhaveri, Komal L., Schmid, Peter, Loi, Sherene, Saura, Cristina, Im, Seock-Ah, Sunpaweravong, Patrapim, Li, Huiping, Musolino, Antonino, Zhang, Qingyuan, Nowecki, Zbigniew, Leung, Roland Ching-Yu, Thanopoulou, Eirini, Shankar, Noopur, Lei, Guiyuan, Devine, Jacob, Stout, Thomas J, Loibl, Sibylle
Published in Journal of clinical oncology (01.06.2024)

Get full text

Journal Article

Efficacy and tolerability of sorafenib in unresectable/advanced hepatocellular carcinoma patients: Real-life experience in a Hong Kong tertiary liver cancer institute

Efficacy and tolerability of sorafenib in unresectable/advanced hepatocellular carcinoma patients: Real-life experience in a Hong Kong tertiary liver cancer institute

by Yau, Thomas Cheung, Tang, Vikki, Leung, Roland Ching-Yu, Kwok, Gin Wai, Chiu, Joanne Wing-Yan, Cheung, Tan To
Published in Journal of clinical oncology (01.02.2019)

Get full text

Journal Article

Nivolumab/pembrolizumab in Child-Pugh grade B/C patients with advanced HCC

Nivolumab/pembrolizumab in Child-Pugh grade B/C patients with advanced HCC

by Wong, Jeffrey Sum Lung, Kwok, Gin Wai, Tang, Vikki, Li, Bryan, Leung, Roland Ching-Yu, Chiu, Joanne Wing Yan, Ma, Ka Wing, She, Wong-Hoi, Tsang, Wing Yan Josephine, Cheung, Tan To, Yau, Thomas
Published in Journal of clinical oncology (20.05.2021)

Get full text

Journal Article

Outcomes of tyrosine kinase inhibitors after immunotherapy in advanced hepatocellular carcinoma: A multi-center study

Outcomes of tyrosine kinase inhibitors after immunotherapy in advanced hepatocellular carcinoma: A multi-center study

by Yau, Thomas, Lee, Joycelyn Jie Xin, Wong, Jeffrey Sum Lung, Tang, Vikki, Chan, Jess, Kwok, Gin Wai, Chiu, Joanne Wing Yan, Leung, Roland Ching-Yu, Li, Bryan, Tsang, Wing Yan Josephine, Cheung, Tan To, Choo, SuPin, Tai, Wai Meng David
Published in Journal of clinical oncology (20.05.2021)

Get full text

Journal Article

Phase 1A, first-in-human study of ARB202, bispecific antibody to CDH17 and CD3, in advanced gastrointestinal malignancies expressing CDH17

Phase 1A, first-in-human study of ARB202, bispecific antibody to CDH17 and CD3, in advanced gastrointestinal malignancies expressing CDH17

by Leung, Roland Ching-Yu, Yau, Thomas, Wong, Dennis A, Luk, John Moon, de Souza, Paul L.
Published in JCO global oncology (01.08.2023)

Get full text

Journal Article

$A phase II study of capecitabine, oxaliplatin and irinotecan (XELOXIRI) as salvage therapy in patients with refractory metastatic colorectal cancer$

A phase II study of capecitabine, oxaliplatin and irinotecan (XELOXIRI) as salvage therapy in patients with refractory metastatic colorectal cancer

by Kwok, Gin Wai, Leung, Roland Ching-Yu, Chiu, Joanne, Tang, Vikki, Yau, Thomas Cheung
Published in Journal of clinical oncology (20.05.2017)

Get full text

Journal Article

The use of cabozantinib in advanced hepatocellular carcinoma (HCC): Hong Kong multi-center experience

The use of cabozantinib in advanced hepatocellular carcinoma (HCC): Hong Kong multi-center experience

by Dong, Yawen, Leung, Thomas Wai-Tong, Kwok, Gin Wai, Tang, Vikki, Li, Bryan, Leung, Roland Ching-Yu, Chiu, Joanne Wing Yan, Wong, Jeffrey Sum Lung, Ma, Ka Wing, She, Wong Hoi, Tsang, Wing Yan Josephine, Cheung, Tan To, Yau, Thomas
Published in Journal of clinical oncology (20.01.2021)

Get full text

Journal Article

Association of early recurrence within one year of liver transplant for hepatocellular carcinoma with poor survival

Association of early recurrence within one year of liver transplant for hepatocellular carcinoma with poor survival

by Li, Bryan Cho Wing, Chiu, Joanne Wing Yan, Yau, Thomas, Leung, Roland Ching-Yu, Tang, Vikki, Shing, Kit Bong, Kwok, Gin Wai, Cheung, Tan To, She, Wong Hoi, Ma, Ka Wing
Published in Journal of clinical oncology (20.01.2021)

Get full text

Journal Article

$Ipilimumab and nivolumab/pembrolizumab in advanced hepatocellular carcinoma refractory to prior immune checkpoint inhibitors$

Ipilimumab and nivolumab/pembrolizumab in advanced hepatocellular carcinoma refractory to prior immune checkpoint inhibitors

by Wong, Jeffrey Sum Lung, Kwok, Gin Wai, Tang, Vikki, Li, Bryan, Leung, Roland Ching-Yu, Chiu, Joanne Wing Yan, Ma, Ka Wing, She, Wong-Hoi, Tsang, Wing Yan Josephine, Cheung, Tan To, Yau, Thomas
Published in Journal of clinical oncology (20.01.2021)

Get full text

Journal Article

Randomized phase II trial of sorafenib, capecitabine, and oxaliplatin (SECOX) versus single agent sorafenib in patients with advanced hepatocellular carcinoma

Randomized phase II trial of sorafenib, capecitabine, and oxaliplatin (SECOX) versus single agent sorafenib in patients with advanced hepatocellular carcinoma

by Kwok, Gin Wai, Tang, Vikki, Leung, Roland Ching-Yu, Lee, Ann-Shing, Law, Ada, Chiu, Joanne Wing Yan, Li, Bryan, Cheung, Tan To, Yau, Thomas
Published in Journal of clinical oncology (20.05.2019)

Get full text

Journal Article

Randomized phase II trial of sorafenib, capecitabine and oxaliplatin (SECOX) versus single agent sorafenib in patients with advanced hepatocellular carcinoma

Randomized phase II trial of sorafenib, capecitabine and oxaliplatin (SECOX) versus single agent sorafenib in patients with advanced hepatocellular carcinoma

by Yau, Thomas Cheung, Tang, Vikki, Leung, Roland Ching-Yu, Kwok, Gin Wai, Lee, Ann-Shing, Law, Ada, Chiu, Joanne, Li, Bryan, Cheung, Tan To
Published in Journal of clinical oncology (01.02.2019)

Get full text

Journal Article

Cabozantinib in advanced HCC patients previously treated with immune checkpoint inhibitors: A territory-wide cohort study

Cabozantinib in advanced HCC patients previously treated with immune checkpoint inhibitors: A territory-wide cohort study

by Wong, Jeffrey Sum Lung, Dong, Yawen, Tang, Vikki, Leung, Thomas Wai-Tong, Yeung, Cynthia SY, Tai, Anna, Law, Ada, Shum, Tracy Cy, Kwok, Gin Wai, Li, Bryan, Leung, Roland Ching-Yu, Chiu, Joanne Wing Yan, Ma, Ka Wing, She, Wong-Hoi, Tsang, Wing Yan Josephine, Cheung, Tan To, Yau, Thomas
Published in Journal of clinical oncology (20.05.2021)

Get full text

Journal Article

Thyroid Immune-Related Adverse Events in Patients with Cancer Treated with anti-PD1/anti-CTLA4 Immune Checkpoint Inhibitor Combination: Clinical Course and Outcomes

Thyroid Immune-Related Adverse Events in Patients with Cancer Treated with anti-PD1/anti-CTLA4 Immune Checkpoint Inhibitor Combination: Clinical Course and Outcomes

by Lui, David Tak Wai, Lee, Chi Ho, Tang, Vikki, Fong, Carol Ho Yi, Lee, Alan Chun Hong, Chiu, Joanne Wing Yan, Leung, Roland Ching Yu, Kwok, Gerry Gin Wai, Li, Bryan Cho Wing, Cheung, Tan To, Woo, Yu Cho, Lam, Karen Siu Ling, Yau, Thomas
Published in Endocrine practice (01.09.2021)

Get more information

Journal Article